Education
About Us
Working with TipRanks
Follow Us
Roivant Sciences (ROIV)
NASDAQ:ROIV
| Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 29.05M | $ 124.80M | $ 61.28M | $ 55.29M | $ 23.80M |
| Gross Profit | $ 28.14M | $ 96.83M | $ 48.15M | $ 46.32M | $ 21.74M |
| Operating Income | $ -1.00B | $ 4.24B | $ -1.18B | $ -1.35B | $ -1.07B |
| EBITDA | $ -1.10B | $ 4.31B | $ -1.18B | $ -916.71M | $ -895.74M |
| Net Income | $ -171.98M | $ 4.35B | $ -1.01B | $ -845.26M | $ -809.23M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.89B | $ 6.54B | $ 1.68B | $ 2.06B | $ 2.13B |
| Total Assets | $ 5.44B | $ 7.22B | $ 2.39B | $ 2.59B | $ 2.69B |
| Total Debt | $ 100.17M | $ 499.75M | $ 481.40M | $ 283.89M | $ 244.98M |
| Net Debt | $ -2.62B | $ -6.04B | $ -1.20B | $ -1.78B | $ -1.81B |
| Total Liabilities | $ 249.74M | $ 773.95M | $ 782.02M | $ 523.70M | $ 527.69M |
| Stockholders' Equity | $ 4.69B | $ 5.97B | $ 1.16B | $ 1.66B | $ 1.80B |
| Cash Flow | |||||
| Free Cash Flow | $ -844.05M | $ -766.65M | $ -856.08M | $ -695.16M | $ -557.94M |
| Operating Cash Flow | $ -839.45M | $ -765.27M | $ -843.39M | $ -677.73M | $ -552.14M |
| Investing Cash Flow | $ -1.77B | $ 5.20B | $ -44.27M | $ 303.30M | $ -31.70M |
| Financing Cash Flow | $ -1.22B | $ 419.36M | $ 499.46M | $ 306.79M | $ 456.26M |